Your browser doesn't support javascript.
loading
ARMCX3 Mediates Susceptibility to Hepatic Tumorigenesis Promoted by Dietary Lipotoxicity.
Mirra, Serena; Gavaldà-Navarro, Aleix; Manso, Yasmina; Higuera, Mónica; Serrat, Román; Salcedo, María Teresa; Burgaya, Ferran; Balibrea, José Maria; Santamaría, Eva; Uriarte, Iker; Berasain, Carmen; Avila, Matias A; Mínguez, Beatriz; Soriano, Eduardo; Villarroya, Francesc.
Afiliação
  • Mirra S; Department of Cell Biology, Physiology and Immunology, University of Barcelona, 08007 Barcelona, Spain.
  • Gavaldà-Navarro A; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Manso Y; Department of Biochemistry and Molecular Biomedicine and Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain.
  • Higuera M; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Serrat R; Department of Cell Biology, Physiology and Immunology, University of Barcelona, 08007 Barcelona, Spain.
  • Salcedo MT; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Burgaya F; Liver Diseases Research Group, Vall d'Hebron Institute of Research, VHIR, 08035 Barcelona, Spain.
  • Balibrea JM; Department of Cell Biology, Physiology and Immunology, University of Barcelona, 08007 Barcelona, Spain.
  • Santamaría E; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Uriarte I; Pathology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Berasain C; Department of Cell Biology, Physiology and Immunology, University of Barcelona, 08007 Barcelona, Spain.
  • Avila MA; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Mínguez B; Endocrine, Metabolic and Bariatric Surgery Unit, General Surgery Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
  • Soriano E; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Villarroya F; Hepatology Programme, CIMA-University of Navarra, IdiSNA, 31009 Pamplona, Spain.
Cancers (Basel) ; 13(5)2021 Mar 05.
Article em En | MEDLINE | ID: mdl-33807672
ABSTRACT
ARMCX3 is encoded by a member of the Armcx gene family and is known to be involved in nervous system development and function. We found that ARMCX3 is markedly upregulated in mouse liver in response to high lipid availability, and that hepatic ARMCX3 is upregulated in patients with NAFLD and hepatocellular carcinoma (HCC). Mice were subjected to ARMCX3 invalidation (inducible ARMCX3 knockout) and then exposed to a high-fat diet and diethylnitrosamine-induced hepatocarcinogenesis. The effects of experimental ARMCX3 knockdown or overexpression in HCC cell lines were also analyzed. ARMCX3 invalidation protected mice against high-fat-diet-induced NAFLD and chemically induced hepatocarcinogenesis. ARMCX3 invalidation promoted apoptotic cell death and macrophage infiltration in livers of diethylnitrosamine-treated mice maintained on a high-fat diet. ARMCX3 downregulation reduced the viability, clonality and migration of HCC cell lines, whereas ARMCX3 overexpression caused the reciprocal effects. SOX9 was found to mediate the effects of ARMCX3 in hepatic cells, with the SOX9 interaction required for the effects of ARMCX3 on hepatic cell proliferation. In conclusion, ARMCX3 is identified as a novel molecular actor in liver physiopathology and carcinogenesis. ARMCX3 downregulation appears to protect against hepatocarcinogenesis, especially under conditions of high dietary lipid-mediated hepatic insult.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha